A kit preparation that enables drug dose adjustment. The kit preparation includes a bag which contains an infusion solution or pure water and at least one drug enclosing part in which a drug is enclosed and which is provided with a sealing part. The drug enclosing part is connected to the bag via the sealing part; and, when the sealing part is released, the bag is communicated with the drug enclosing part and thus the drug is poured into the bag so that a dispensing work can be carried out.

This disclosure provides a perfusion device, an anesthetic vaporizer, and an anesthetic machine. The anesthetic vaporizer includes a vaporizer body and the perfusion device. A feed port and a tank are provided in the vaporizer body. The perfusion device includes a mounting assembly, an ejector rod assembly, and a valve core assembly that is provided with a liquid inlet channel. The mounting assembly includes a mounting seat that is mounted on the feed port and provided with a hollow structure having an opening at both ends. The valve core assembly is movably mounted on one opening of the hollow structure, and the ejector rod assembly is movably mounted on the other opening of the hollow structure and forms a sealed structure with the mounting assembly. The ejector rod assembly may drive the valve core assembly to move toward the tank, and the liquid inlet channel communicates with the hollow structure.

Provided is a medicine container which contributes to improved stability of a protein preparation stored therein. This medicine container for storing a protein preparation contains a hydrogenated block copolymer.

A liquid dispensing device includes a multifunction membrane valve that, in addition to allowing the dispensing of drops with a drop-check mechanism, ensures and isolates the passage of the air to be filtered so that it does not contaminate the liquid in the interior of the dispensing device; it has a reduced number of parts; it facilitates proper assembly by counter pressure, without the need for threads or complex coupling elements; it avoids the need for rotational alignment when assembling the parts, among other advantages.

A top for a plasma storage container includes a top body that defines the structure of the top and seals an opening of the plasma storage container. The top also includes a first opening and a vent opening extending through the top body. A valve mechanism is located at least partially within the top body and includes an aperture therethrough. The aperture opens upon connection of a blunt cannula to provide access to the interior of the plasma storage container. The top also includes a vent filter. The vent filter allows air to vent through the vent opening during plasma collection.

A top for a plasma storage container includes a top body that defines the structure of the top and seals an opening of the plasma storage container. The top also includes a first opening and a vent opening extending through the top body. A valve mechanism is located at least partially within the top body and includes an aperture therethrough. The aperture opens upon connection of a blunt cannula to provide access to the interior of the plasma storage container. The top also includes a vent filter. The vent filter allows air to vent through the vent opening during plasma collection.

Blockchain environments may mix-and-match different encryption, difficulty, and/or proof-of-work schemes when mining blockchain transactions. Each encryption, difficulty, and/or proof-of-work scheme may be separate, stand-alone programs, files, or third-party services. Blockchain miners may be agnostic to a particular coin's or network's encryption, difficulty, and/or proof-of-work schemes, thus allowing any blockchain miner to process or mine data in multiple blockchains. GPUs, ASICs, and other specialized processing hardware components may be deterred by forcing cache misses, cache latencies, and processor stalls. Hashing, difficulty, and/or proof-of-work schemes require less programming code, consume less storage space/usage in bytes, and execute faster. Blockchain mining schemes may further randomize byte or memory block access, further improve cryptographic security.

Blockchain environments may mix-and-match different encryption, difficulty, and/or proof-of-work schemes when mining blockchain transactions. Each encryption, difficulty, and/or proof-of-work scheme may be separate, stand-alone programs, files, or third-party services. Blockchain miners may be agnostic to a particular coin's or network's encryption, difficulty, and/or proof-of-work schemes, thus allowing any blockchain miner to process or mine data in multiple blockchains. GPUs, ASICs, and other specialized processing hardware components may be deterred by forcing cache misses, cache latencies, and processor stalls. Hashing, difficulty, and/or proof-of-work schemes require less programming code, consume less storage space/usage in bytes, and execute faster. Blockchain mining schemes may further randomize byte or memory block access, further improve cryptographic security.

Provided is a packaging container including a bag main body portion having a first surface, a second surface and an opening portion; and a tongue piece portion formed to be continuously extended from the first surface. The bag main body portion and the tongue piece portion have an aluminum vapor-deposited layer on an outside thereof, the packaging container further includes an adhesion portion which is provided on the second surface to be spaced from the opening portion; and a folded-back portion which is provided between the adhesion portion and the opening portion to fold back the tongue piece portion to the opening portion side. A length of the tongue piece portion is a, a length from the opening portion to the folded-back portion is b, and a length from the folded-back portion to the adhesion portion is c. And,
a<b+c.

The invention provides liquid formulation compositions and medicament delivery devices, and methods for preparing and using the same. For example, the liquid formulation composition is an emulsion including a solvent and liquid particles, which includes surfactants and are dispersed in the solvent. The volume average particle size of the liquid particles is less than about 100 μm; the surface tension of the liquid formulation composition is less than about 60 mN/m; and the absolute value of zeta potential is greater than about 15 mV. The containment vessel may be a sprayer or a dropping device. The invention also provides methods for preparation of the liquid formulation compositions and medicament delivery devices as well as methods for using the same in treatment of various diseases and condition, for example, otitis media, otitis externa, rhinitis, sinusitis, lower respiratory tract inflammation, xerostomia (dry mouth), xerophthalmia (dry eyes) and xeromycteria (dry nose).